Antimicrobial Resistance Surveillance Global Market Report 2025

Description

Antimicrobial resistance (AMR) surveillance involves the systematic monitoring and tracking of antimicrobial-resistant microorganisms to detect emerging resistance patterns, guide public health interventions, and inform treatment strategies for infections caused by resistant bacteria, viruses, and fungi.

The primary solutions in AMR surveillance include diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are pre-packaged tools that enable healthcare professionals to rapidly identify antimicrobial-resistant infections in patients. These solutions are applied in clinical diagnostics, public health surveillance, and other areas, serving end users such as hospitals and clinics, research and academic institutes, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The antimicrobial resistance surveillance market research report is one of a series of new reports from The Business Research Company that provides antimicrobial resistance surveillance market statistics, including antimicrobial resistance surveillance industry global market size, regional shares, competitors with an antimicrobial resistance surveillance market share, detailed antimicrobial resistance surveillance market segments, market trends and opportunities, and any further data you may need to thrive in the antimicrobial resistance surveillance industry. This antimicrobial resistance surveillance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial resistance surveillance market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.3 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to increased use of antibiotics in agriculture, overprescription of antibiotics in healthcare, lack of diagnostic testing, poor infection prevention and control practices, global travel and trade.

The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to growing awareness about antimicrobial resistance, advancements in diagnostic technologies, increasing government initiatives and funding, a rise in healthcare-associated infections, and the development of new antibiotics and alternatives. Major trends in the forecast period include artificial intelligence for data analysis, next-generation sequencing technologies, real-time surveillance systems, molecular diagnostic tools, and the integration of big data and machine learning for predictive modeling.

The forecast of 8.3% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restricted access to French antibiotic susceptibility testing panels and British molecular detection reagents, delaying critical public health monitoring.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of infectious diseases is expected to drive the growth of the antimicrobial resistance surveillance market. Infectious diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites and can spread directly or indirectly between individuals. Factors such as climate change, urbanization, and global travel contribute to the rising prevalence of these diseases by facilitating pathogen transmission and increasing human exposure to new microbes. Antimicrobial resistance surveillance plays a crucial role in tracking the spread of resistant pathogens, guiding effective treatment strategies, and shaping public health policies to combat infectious diseases. For example, in February 2024, a report by the UK Health Security Agency revealed a 10.7% increase in tuberculosis (TB) cases in England, with 4,850 cases reported in 2023 compared to 4,380 in 2022. As a result, the increasing prevalence of infectious diseases is fueling the expansion of the antimicrobial resistance surveillance market.

Leading companies in the industry are focusing on innovative technologies, such as advanced diagnostic tools, to improve efficiency, enhance accuracy, reduce costs, and provide better patient outcomes. A diagnostic tool encompasses any device, instrument, software, or methodology used to detect, identify, or assess the presence of a condition, disease, or malfunction. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer of diagnostic products, launched the PA-100 AST Point-of-Care Testing System. This system enables rapid and precise detection of antimicrobial resistance at the point of care, significantly reducing the time required for results compared to conventional laboratory methods, which can take several days. By delivering results in just 30 minutes, it empowers clinicians to make timely and informed decisions regarding infection treatment, minimizing reliance on broad-spectrum antibiotics and aiding efforts to curb antimicrobial resistance.

In January 2024, BioMerieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. This acquisition is aimed at enhancing BioMerieux's capabilities in combating antimicrobial resistance and strengthening its portfolio, particularly by offering digital tools to support antibiotic stewardship. LUMED Inc., an Italy-based company, specializes in healthcare and medical data analysis, with a focus on antimicrobial resistance surveillance.

Major players in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Viatris Inc., Wolters Kluwer NV, Hologic Inc., Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen NV, Cepheid Inc., Shionogi & Co. Ltd., Venatorx Pharmaceuticals Inc., Accelerate Diagnostics Inc., Paratek Pharmaceuticals Inc., Liofilchem Srl, Lumed Inc., OpGen Inc.

North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in antimicrobial resistance surveillance report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the antimicrobial resistance surveillance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antimicrobial Resistance Surveillance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antimicrobial resistance surveillance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antimicrobial resistance surveillance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The antimicrobial resistance surveillance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits; Immunoassay Kits; Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems; Whole Genome Sequencing (WGS) Systems; Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms; AI-Powered Data Analytics Tools; Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services; Data Management & Reporting Services; Consultation & Training Services
Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Becton, Dickinson and Company; Viatris Inc.; Wolters Kluwer NV; Hologic Inc.; Biomerieux SA; Bio-Rad Laboratories Inc.; Bruker Corporation; Qiagen NV; Cepheid Inc.; Shionogi & Co. Ltd.; Venatorx Pharmaceuticals Inc.; Accelerate Diagnostics Inc.; Paratek Pharmaceuticals Inc.; Liofilchem Srl; Lumed Inc.; OpGen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r33966u

1. Executive Summary

2. Antimicrobial Resistance Surveillance Market Characteristics

3. Antimicrobial Resistance Surveillance Market Trends And Strategies

4. Antimicrobial Resistance Surveillance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Antimicrobial Resistance Surveillance Growth Analysis And Strategic Analysis Framework

5.1. Global Antimicrobial Resistance Surveillance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antimicrobial Resistance Surveillance Market Growth Rate Analysis
5.4. Global Antimicrobial Resistance Surveillance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antimicrobial Resistance Surveillance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antimicrobial Resistance Surveillance Total Addressable Market (TAM)

6. Antimicrobial Resistance Surveillance Market Segmentation

6.1. Global Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Kits
Diagnostic Systems
Surveillance Software
Services
6.2. Global Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Diagnostics
Public Health Surveillance
Other Applications
6.3. Global Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research And Academic Institutes
Other End Users
6.4. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR-Based Kits
Immunoassay Kits
Lateral Flow Assay Kits
6.5. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Diagnostic Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Automated Susceptibility Testing Systems
Whole Genome Sequencing (WGS) Systems
Mass Spectrometry-Based Systems
6.6. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Surveillance Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cloud-Based Surveillance Platforms
AI-Powered Data Analytics Tools
Electronic Health Record (EHR)-Integrated Systems
6.7. Global Antimicrobial Resistance Surveillance Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Testing Services
Data Management And Reporting Services
Consultation And Training Services

7. Antimicrobial Resistance Surveillance Market Regional And Country Analysis

7.1. Global Antimicrobial Resistance Surveillance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antimicrobial Resistance Surveillance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antimicrobial Resistance Surveillance Market

8.1. Asia-Pacific Antimicrobial Resistance Surveillance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antimicrobial Resistance Surveillance Market

9.1. China Antimicrobial Resistance Surveillance Market Overview
9.2. China Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antimicrobial Resistance Surveillance Market

10.1. India Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antimicrobial Resistance Surveillance Market

11.1. Japan Antimicrobial Resistance Surveillance Market Overview
11.2. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antimicrobial Resistance Surveillance Market

12.1. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antimicrobial Resistance Surveillance Market

13.1. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antimicrobial Resistance Surveillance Market

14.1. South Korea Antimicrobial Resistance Surveillance Market Overview
14.2. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antimicrobial Resistance Surveillance Market

15.1. Western Europe Antimicrobial Resistance Surveillance Market Overview
15.2. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antimicrobial Resistance Surveillance Market

16.1. UK Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antimicrobial Resistance Surveillance Market

17.1. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antimicrobial Resistance Surveillance Market

18.1. France Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antimicrobial Resistance Surveillance Market

19.1. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antimicrobial Resistance Surveillance Market

20.1. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antimicrobial Resistance Surveillance Market

21.1. Eastern Europe Antimicrobial Resistance Surveillance Market Overview
21.2. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antimicrobial Resistance Surveillance Market

22.1. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antimicrobial Resistance Surveillance Market

23.1. North America Antimicrobial Resistance Surveillance Market Overview
23.2. North America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antimicrobial Resistance Surveillance Market

24.1. USA Antimicrobial Resistance Surveillance Market Overview
24.2. USA Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antimicrobial Resistance Surveillance Market

25.1. Canada Antimicrobial Resistance Surveillance Market Overview
25.2. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antimicrobial Resistance Surveillance Market

26.1. South America Antimicrobial Resistance Surveillance Market Overview
26.2. South America Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antimicrobial Resistance Surveillance Market

27.1. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antimicrobial Resistance Surveillance Market

28.1. Middle East Antimicrobial Resistance Surveillance Market Overview
28.2. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antimicrobial Resistance Surveillance Market

29.1. Africa Antimicrobial Resistance Surveillance Market Overview
29.2. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Solution, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antimicrobial Resistance Surveillance Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antimicrobial Resistance Surveillance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antimicrobial Resistance Surveillance Market Competitive Landscape And Company Profiles

30.1. Antimicrobial Resistance Surveillance Market Competitive Landscape
30.2. Antimicrobial Resistance Surveillance Market Company Profiles
- 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Antimicrobial Resistance Surveillance Market Other Major And Innovative Companies

31.1. Viatris Inc.
31.2. Wolters Kluwer NV
31.3. Hologic Inc.
31.4. Biomerieux SA
31.5. Bio-Rad Laboratories Inc.
31.6. Bruker Corporation
31.7. Qiagen NV
31.8. Cepheid Inc.
31.9. Shionogi & Co. Ltd.
31.10. Venatorx Pharmaceuticals Inc.
31.11. Accelerate Diagnostics Inc.
31.12. Paratek Pharmaceuticals Inc.
31.13. Liofilchem Srl
31.14. Lumed Inc.
31.15. OpGen Inc.

32. Global Antimicrobial Resistance Surveillance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antimicrobial Resistance Surveillance Market

34. Recent Developments In The Antimicrobial Resistance Surveillance Market

35. Antimicrobial Resistance Surveillance Market High Potential Countries, Segments and Strategies

35.1 Antimicrobial Resistance Surveillance Market In 2029 - Countries Offering Most New Opportunities
35.2 Antimicrobial Resistance Surveillance Market In 2029 - Segments Offering Most New Opportunities
35.3 Antimicrobial Resistance Surveillance Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer